Chair Phillip Ramsey SAIC-Frederick Frederick, MD UNITED STATES Chair-Elect Deepa S. Deshpande, Ph.D., RAC Cerexa Inc (subsidiary of Forest Laboratories Inc) Alameda, CA UNITED STATES Vice Chair Andrew M. Vick, Ph.D. BioPharma Services Saint Charles, MO UNITED STATES Secretary/Treasurer Bhaskara R. Jasti, Ph.D. University of the Pacific Stockton, CA United States Past Chair Russell S. Weiner, Ph.D. Bristol-Myers Squibb, Inc. Lawrenceville, NJ UNITED STATES Member at Large Peter A. Crooks, Ph.D. University of Kentucky
College of Pharmacy Lexington, KY UNITED STATES National Biotechnology Conference Screeners Committee Sudip K. Das, Ph.D. Butler University Indianapolis, IN Annual Meeting Screeners Committee Sudip K. Das, Ph.D. Butler University Indianapolis, IN | Annual Meeting Program Committee Deepa S. Deshpande, Ph.D., RAC Cerexa Inc (subsidiary of Forest Laboratories Inc) Alameda, CA UNITED STATES Awards Committee Mark A. Staples, Ph.D. Cusp PharmaTech Consulting LLC Cambridge, MA United States Content Advisory Cmte Masood U. Khan Covance Laboratories Chantilly, VA UNITED STATES National Biotech Progrming Committee Jeffrey M. Sailstad Sailstad and Associates Durham, NC UNITED STATES Student/Postdoc Committee William Nowatzke CEDRA Corporation Austin, TX UNITED STATES Fellows Committee Wayne R. Gombotz, Ph.D. Omeros Corporation Seattle, WA United States Membership Committee Kamal L. Egodage, Ph.D. Eli Lilly Indianapolis, IN UNITED STATES Nominations Committee Phillip Ramsey SAIC-Frederick Frederick, MD UNITED STATES | Program Coordination Committee Lawrence X. Yu, Ph.D. Food and Drug Administration Office of Generic Drugs Rockville, MD Publications Committee Masood U. Khan Covance Laboratories Chantilly, VA UNITED STATES Webmasters Committee Mr. Christian Grimstein College of Pharmacy, University of Florida Gainesville, FL UNITED STATES Member Strategic Oversight Committee Kamal L. Egodage, Ph.D. Eli Lilly Indianapolis, IN UNITED STATES Student Rep Mr. Tarik A. Khan University of Texas Austin, TX United States Programming Committee Deepa S. Deshpande, Ph.D., RAC Cerexa Inc (subsidiary of Forest Laboratories Inc) Alameda, CA UNITED STATES Staff Liaison Stacey Anne May Wierzba AAPS Arlington, VA UNITED STATES Biomarkers in Translational Medicine Focus Group Pei Fan Bai, Ph.D. OCP/OTS/CDER/FDA Silver Spring, MD Pharmacogenomics (PGx) Focus Group Majid Moridani, Pharm.D., Ph.D. Texas Tech University Health Sciences Center Amarillo, TX Ligand Binding Assay Bioanalytical Focus Group Bonita J. Rup, Ph.D. Wyeth Research Andover, MA United States Sterile Products Focus Group Lavinia Marina Lewis, Ph.D. Pfizer Chesterfield, MO United States Preformulation Focus Group Tapan K. Das, Ph.D. Pfizer, St. Louis Chesterfield, MO United States CRO Focus Group Shang-Ying Peter King, Ph.D. Quest Pharmaceutical Services, L.L.C. Newark, DE United States Generic Pharmaceuticals Focus Group Mei-Ling Chen, Ph.D Office of Pharmaceutical Science, Food and Drug Administration Rockville, MD UNITED STATES Lipid-Based Drug Delivery Systems Focus Group Panayiotis P. Constantinides, Ph.D. Biopharmaceutical and Drug Delivery Consulting, LLC Gurnee, IL UNITED STATES Nucleic Acid Based Therapeutics Focus Group Alain P. Rolland, Ph.D. Vical Incorporated San Diego, CA UNITED STATES Preformulation Focus Group Eric J. Munson, Ph.D University of Kansas Lawrence, KS Preformulation Focus Group Eric J. Munson, Ph.D University of Kansas Lawrence, KS Protein Aggregation & Immunogenicity Focus Group Dr. Satish K. Singh Pfizer, Inc. Chesterfield, MO United States |